Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
March 9, 2021
Patent Application Number
16904261
Date Filed
June 17, 2020
Patent Citations
Patent Citations Received
Patent Primary Examiner
Patent abstract
Methods for the treatment of CD30-expressing cancers are provided. The methods comprise administering to a subject in need thereof a weekly dose of from about 0.8 mg/kg to about 1.8 mg/kg of an antibody-drug conjugate compound having formula (I); or a pharmaceutically acceptable salt thereof; wherein: mAb is an anti-CD30 antibody unit, S is a sulfur atom of the antibody, A- is a Stretcher unit, and p is from about 3 to about 5.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
